Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood
Phase 3
Terminated
- Conditions
- RhabdomyosarcomaMalignant Soft Tissue
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2005-09-13
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 400
- Registration Number
- NCT00162695
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Phase 2
Completed
- Conditions
- Glioma
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 87
- Registration Number
- NCT00147160
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
π¬π§Bristol Royal Hospital for Children, Bristol, United Kingdom
Oxaliplatin With Gemcitabine in Patients With Carcinoma of the Urothelial Tract
Phase 2
Terminated
- Conditions
- Carcinoma, Transitional Cell
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2005-08-24
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 28
- Registration Number
- NCT00127595
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Early Tracheotomy Versus Prolonged Endotracheal Intubation in Intensive Care Unit (ICU) Patients
Phase 3
Terminated
- Conditions
- Respiratory Insufficiency
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2005-08-25
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 468
- Registration Number
- NCT00127621
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
Phase 2
Suspended
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 37
- Registration Number
- NCT00127088
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Phase 2
- Conditions
- Germ Cell Tumor
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 37
- Registration Number
- NCT00127049
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer
Phase 3
Completed
- Conditions
- MetastasisColorectal Cancer
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 570
- Registration Number
- NCT00126256
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary
Phase 3
- Conditions
- Carcinoma
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 192
- Registration Number
- NCT00126269
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer
Phase 2
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-08-03
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 55
- Registration Number
- NCT00126230
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
Phase 2
- Conditions
- Carcinoma of the AppendixColorectal CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2004-05-04
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Registration Number
- NCT00006112
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Β© Copyright 2025. All Rights Reserved by MedPath